Antimicrobial Stewardship is complex

Renewed attention is being focused on the importance of antimicrobial stewardship in reducing the development of antimicrobial resistance. Recent regulatory changes provide meaningful impetus for health-system pharmacists to evaluate the effectiveness of their antimicrobial stewardship (AMS) program. These regulatory changes include:

In this article series, we aim to deliver concise, practical, and actionable items as a resource to busy clinicians to help them assess their AMS programs, identify opportunities for improvement, and succeed in meeting any accreditation and regulatory requirements.

Connect with a representative
Discover how Sentri7® helps your pharmacy teams optimize antimicrobial use and comply with regulatory requirements.

2024 AUR Reporting Updates

CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within Promoting Interoperability Program beginning in 2024. Talk to your Quality leader about the AUR reporting requirement to determine how to avoid penalties for non-reporting.

To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).

Customers succeed with Sentri7
With AUR reporting requirements coming into play, we don’t have to scramble here at the last minute trying to figure out how we’re going to get into compliance. Thanks to Sentri7, we’re already there.
Pamela Barefoot, PharmD, Director of Pharmacy, Sampson Regional Medical Center
Back To Top